chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flu like symptoms; Fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. On 06-Apr-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Fever) had resolved. Not Provided          Patient reported that she was taking concomitant medication.  Patient reported that after receiving the first dose of vaccine, she had lump in her neck which still persisted. Treatment medication included antibiotics. Action taken with mRNA-1273 in response to the events were not applicable.   This case was linked to MOD-2021-100485 (Patient Link).
Fever, urticarial rash to face, neck trunk, and extremities, arthralgias and swelling to hands, feet, ankles, left knee and left elbow occurring 4 weeks after vaccine lasting for 4 days in hospital after 2 days at home. still resolving slowly
SYMPTOMS OF COUGH; RUNNY NOSE; FEELING OF BEING STOPPED UP IN THE HEAD; This spontaneous report received from a patient concerned a 51 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A121A expiry: UNKNOWN) dose was not reported, administered on 30-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On 13-JAN-2022, Laboratory data included: COVID-19 antigen test (NR: not provided) Negative. On an unspecified date, the patient experienced symptoms of cough, runny nose, and feeling of being stopped up in the head. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the symptoms of cough, runny nose and feeling of being stopped up in the head was not reported. This report was non-serious.
Patient presented to clinic with cellulitis at vaccination site. The site at which the patient was immunized is lower than the recommended distance from the acromion process. Approximate 10cm lesion at time of appointment. Patient denied shortness of breath or difficulty breathing, no generalized rashes present, negative for axial lymphadenopathy. Lesion was erythemic and hot to touch, tender to palpation. Physician Assistant prescribed Keflex for treatment. Patient advised to follow up with the clinic if his symptoms do not improve.
24Nov97 pt recv 1 dose vax. 6 hr post vax pt devel allergic rash "all over; a red rash; pt very itchy". Pt tx w//Benadryl. This is in follow-up to report(s) previously submitted om 4/15/1998. Information jas been received from a female consumer concerning her 13-year-old daughter with an allergy to bacitracin who on approximately 24-NOV-1997 was vaccinated with VARIVAX. Six hours post-vaccination, the patient developed an allergic rash "all over, a red rash, patient very itchy." The patient was treated by the mother per pediatrician's phone order with BENADRYL. The physician did not see the patient's rash. The BENADRYL was effective. It was noted that the patient had an allergic reaction to the neomycin in the vaccine, Additional information has been requeted.
My period started on May 11th and ended on May 15th (normal cycle).  I then had a second period start on May 20th. My cycle is regular and this is not something that commonly occurs.  I have not had a; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 08May2021 at 15:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included supraventricular tachycardia (SVT) and shellfish allergy. Concomitant medications included diltiazem (MANUFACTURER UNKNOWN) for unknown indication and from an unknown date. The patient previously received codeine (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 17Apr2021 at 15:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient's period started on 11May2021 and ended on 15May2021 which was normal cycle.  The patient then had a second period on 20May2021. The patient cycle was regular and this was not something that commonly occurs. The patient not had any medicine changes or illnesses. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event, period started on 11May2021 and ended on 15May2021 which was normal cycle, had a second period on 20May2021 and cycle was regular and this was not something that commonly occurs was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
We processed a prescrption with Fluzone quad but we administered Flublok . Patient does not have any side effects.
Patient started to experience dizziness. Has remained since 11/3/14. Onset was two days after receiving the influenza vaccination.
SkinRash Narrative:  Redness to arm . Had previous rash with vaccine.  Ok'd by PCP  for second dose. Observed for 30 and ice placed on injection site. Oral Benadryl not taken sent with him as a safety measure. NO other concerns  Other Relevant History:
Skilled nursing facility reported that patient was hospitalized on 7/27/2021.  Patient received a chest x-ray on 7/25/2021 which indicated right lower lobe pneumonia.  Began antibiotics but signs/symptoms worsened.  Sent to hospital on 7/27/2021 and received a positive Covid-19 PCR test upon admission. Facility reported the patient had a fever of 100.4 degrees and shortness of breath.
I woke up with a very tender and swollen armpit on the arm where I got my vaccine: and it's been very uncomfortable; I woke up with a very tender and swollen armpit on the arm where I got my vaccine: and it's been very uncomfortable; I woke up with a very tender and swollen armpit on the arm where I got my vaccine: and it's been very uncomfortable; Dose number: 3; This is a spontaneous report from a contactable reporter (consumer or other non HCP). The reporter is the patient.  A 32-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in left arm, administration date 02Jan2022 at 15:30 (Lot number: unknown) at the age of 32 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Blood pressure increased" (unspecified if ongoing), notes: Mildly elevated blood pressure and "Penicillin allergy" (unspecified if ongoing), notes: Known allergies: Penicillin. Concomitant medication included: VITAMIN D. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot Number: UNKNOWN; Anatomical location: Left Arm), administration date: 13Apr2021, when the patient was 32 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE; Lot Number: UNKNOWN; Anatomical location: Left Arm), administration date: 04May2021, when the patient was 32 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 02Jan2022 at 15:30, outcome "unknown", described as "Dose number: 3"; AXILLARY PAIN (non-serious), SWELLING (non-serious), DISCOMFORT (non-serious) all with onset 03Jan2022, outcome "not recovered", and all described as "I woke up with a very tender and swollen armpit on the arm where I got my vaccine: and it's been very uncomfortable". Therapeutic measures were not taken as a result of axillary pain, swelling and discomfort.  Additional information: The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  The lot number for BNT162b2 was not provided and will be requested during follow up.
5 days after first dose of Moderna Covid-19 vaccine, pt noticed his leg was swelling and told his doctor that his leg was swollen at a routine doctor visit that was scheduled ahead of time prior to vaccine. The doctor told the patient to go next door to vascular clinic. They did an ultrasound and found an acute DVT and chronic deep vein thrombosis. Pt was put on Eliquis the same day (4/12/21) to treat the issue. Mild swelling is still present in leg, but pt was cleared by Dr. to receive second dose which he did on 5/5/21.
Patient passed out/fainted, after shot and walking hit his head. Patient was taken to ER via ambulance and had a concussion. Pt was doing okay the next day.
This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided. On 28-NOV-2018, the patient was vaccinated with improperly stored VAQTA (lot # R013859, expiration date 14-JUN-2019) for prophylaxis (strength, dose detail, anatomical location and route of administration were not reported). No adverse effect was reported. The vaccine was exposed to temperature excursion between 0 degree Celsius (C) and 1 degree C for a time frame of 19 minutes and between 9 degree C and 25 degree C for 1 hour without previous temperature excursion. Data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1901USA001125.
Got 1st shot at 17yrs; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Got 1st shot at 17yrs) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Got 1st shot at 17yrs). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Got 1st shot at 17yrs) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.   Patient was due for 2nd shot 14-Jun-2021.  Treatment information not reported.
Headache, NauseaVomiting, Severe site pain, chills, severs fatigue, lightheadedness. thirsty, loss of appetite, shortness of breath
Circular area (1 3/4"x1 1/4") of mild erythema to posterior right arm with smaller central area of erythema.  Warm to touch. Developed on the night of 6/30/09. Area unchanged during exam today. Per patient, the area is tender to the touch.
Information has been received from a physician concerning a 9 year old female who on 06-MAY-1999 was vaccinated with a first 0.5ml dose of VARIVAX.  The date of the second 0.5ml dose of VARIVAX (Lot # 656286/1507F) was not provided.  The patient developed a large and red swelling of the injection site from her shoulder up to her elbow after receiving the second dose of VARIVAX.  Unspecified medical attention was sought.  No product quality complaint was involved.  This is one of two reports received from the same source.  Additional information has been requested.
Throat swelling, trouble breathing, hives, rapid heartbeat & dizziness. About 10 minutes after having received vaccination.
Oh ok I wrote this earlier but I?ll write it again I got my vaccine at 1:15 I got there early so they have it to me then as opposed to the 2:15 appointment I felt a tightness/ lump in the throat as soon as I got it but I could talk fine and everything was fine as I was taking to people around me I left them came back at 2:15 the  person in the pharmacy I had a reaction he gave me a Benadryl and I get fine and he kept me around a bit longer I?m sure he filled the information as he asked for my info and everything then at 4:57 I got some  small hives on my right arm not the arm I got it on as I got it on my left arm which went away in 20mins then I went to my local hospital just to be safe and it went away mostly when I got there around 5ish I think? Then they gave me prednisone and reported it as a drug allergy I also got se. wry small hives on Thursday on my hand which went away soon after it came and I?m really hoping I can get a second dose and be fully vaccinated as it was a severe reaction
Loss of feeling in arm; Random tingling; falling asleep; This is a spontaneous report received from a contactable reporter (consumer). The reporter is the patient.   A 30 year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), unspecified route of administration, administered in left arm, administration date 22Nov2021, (Batch/Lot number: unknown) at the age of 30 years as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, DOSE 1, SINGLE, Lot Number: Unknown, Route of administration: Unspecified, Anatomical site: left arm), administration date: Unknown, for COVID-19 immunisation. The following information was reported: SENSORY LOSS (non-serious), PARAESTHESIA (non-serious) and SOMNOLENCE (non-serious), all with onset 2021, outcome "not recovered", described as "Loss of feeling in arm, Random tingling and falling asleep". Therapeutic measures were not taken as a result of sensory loss, paraesthesia and somnolence. Additional information: The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Initial information was received from a consumer on 19 September 2013. A adult male patient (age not reported), had no medical history reported, received a dose of ADACEL vaccine (route, Dose, site of administration and batch number were not reported) and TYPHIM VI (route, Dose, Site of administration and batch number were not reported) on 17 September 2013. Patient had no concomitant medication reported. It was reported that the on 19 September 2013 patient had experienced sore arm, neck and back as well as a temperature was recorded of 100.4. At the time of report the outcome of event was unknown. List of document reported was none. Company Comment: Lab Tests: Test Name Coll. Date Result Unit Low Value High Value. Body temperature 19-SEP-2013 100.4 Unknown Unknown Unknown. Confirmatory Tests:
TDAP given on 4/24/14. Per clt's mother on 4/26/14, clt stated area of injection was itching. When observed by clt's mother a reddened/raised area the size of a nickle was noted. Clt's mother stated the she did not have a fever or diffuculity breathing.  Clt was taken to an outpt. clinic on Sunday 4/27/14. She was advised to apply cool compresses as needed and give her daughter Benadryl if needed.
Got reaction first time ever; Initial information received on 19-Oct-2021 regarding an unsolicited non-valid Social Media non-serious case received from a consumer/non-health care professional.  This case involves a patient (unknown age and gender) who got reaction first time ever (vaccination complication) after receiving INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date not reported) via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a reaction first time ever (vaccination complication, non-serious) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was unknown for the reported event.  There will be no information on the batch number for this case.
Left arm (where injection given) very sore (difficulty using left arm); chills and high fever (up to 103 degrees), fatigue, headache.  Fever broke about 15 hours later.  Soreness lasted a couple of days.
24 hours after the vaccination, my arm started hurt, the next 2 my arm was red, a diameter of 4 inches, I had nausea, migraine, fever. I had to rotate  Motrin and Tylenol every 4 hours. I have recovered from all my symptoms except I still have massive headaches, my vision changed. I noticed something different with my eyes and it was pretty immediate after my vaccination, within 3 days. I had just had a vision check up, prior to the vaccine. Now my vision has changed, I see blurry now and I continually have real bad headaches, migraine type headaches. And I never had headaches before. I have to take Tylenol and Motrin every day for my headaches. It's caused me anxiety and loss of hope.
11 of 5 pts who had a reaction following vax; pt exp a rash & numbness of the lips;
I became very ill after taking tge flu shot. I had a fever of 102 and had to go to emergency room for treatment yesterday 1/9/20 . i developed a horrible cough and had alot of phlem i also had vwey bad chills and sweats.
H1N1 mist was provided to pt during early pregnancy. Provider was not aware pt. was pregnant at the time she administered vaccine. Pt. not "late"on menstrual cycle at time of administration.
This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL OVERDOSE (Was given 0.5 ml of Moderna as a booster dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported.On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (Was given 0.5 ml of Moderna as a booster dose). At the time of the report, ACCIDENTAL OVERDOSE (Was given 0.5 ml of Moderna as a booster dose) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.The  concomitant medications on use were not provided.No treatment information was provided.Reporter did not allow further contact.
I woke up and I couldn't hear well from my right ear. I didn't have any other symptoms like sneezing, mucus, or coughing. That first day I just felt strange. The next day I started having stomach issues. I was going to the bathroom very frequently. I didn't have any serious symptoms. I kept working from home. I kept not hearing well for 2 or 3 days. The stomach issues lasted for about 5 or 6 days. It took me a couple of weeks to feel 100% completely recovered.
A few hours after vaccine, right arm started to get red and swell. Patient had chills, fever, headache. Feeling unwell. Two to three days later she felt like she had Covid-19 again.  Right Arm continued to swell from shoulder to elbow for 3 weeks.  The arm was hot to the touch. Fever, headache, chills, diarrhea for 3 days.  Had Covid-19 feeling all over again. Poor taste and sense of dread. Did not seek medical treatment for swelling in arm or symptoms.
The patient had three dosis of the vaccine before the administration. The patient classify for the 2nd Booster beacause of his age. The dosis that should be administrated was a Booster of Moderna (0.25mL) after four months of the last vaccine administrated (01/13/2022). The new dosis was administrated below the four months especify by the manufacturer.
A few days post vax, the pt was working in his yard, that night experienced left arm pain lasting for a week. On 10/29, the pt went to work even though bottoms of feet hurt. On 11/4, the bottoms of his feet were hurting again. On 11/9, the pt again had pain in feet and joint pain in hands and feet especially ankles, ankles swollen.
Small knot under injection site around 1cm. Numerous red spots some with central papules and one with a scab.
Initial report was received from a healthcare professional on 10 January 2013. A 24-year-old female patient, who had no relevant medical history with not any illness at the time of vaccination and concomitant medications were not reported, had received intradermal FLUZONE ID (Batch number UT4466BA, expiration date 04/02/2013) in left arm on 09 January 2013 in the evening. On 09 January 2013 at night, the patient felt her skin like sandpaper and had difficulty in sleeping. On 10 January 2013, the patient had pain in both palms and fingers and had hard time holding her toothbrush. The corrective treatment and laboratory investigations were not reported. At the time of this report, the patient had not recovered from the events. Documents held by sender: None.
Delusions; wandering (attempting to leave the home with no purpose); This is a spontaneous report from a contactable consumer.  A 70-year-old female patient (not pregnant) received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EL3249), via an unspecified route of administration in left arm on 16Jan2021 at 11:30 AM (at the age of 70-years-old) at single dose for covid-19 immunisation.  The patient had a history of Early-onset Alzheimer's, high blood pressure and allergy to fire ants (Allergy to insect sting resulted in anaphylaxis). Relevant concomitant medications included memantine hydrochloride (NAMENDA), amlodipine, clopidogrel and atorvastatin. On 22Jan2021 the patient experienced delusions. Believing that people are trying to get into home. Belief that people on TV are in her home and speaking with her. Frequency and severity have increased since second dose. Also wandering (attempting to leave the home with no purpose), patient has dementia.  Clinical outcome of the events was not recovered.
CLIENT RECEIVED BRUISING BELOW THE INJECTION SITE ON THE ARM. BRUISING WAS RED, GREEN, YELLOW, AND DARK BROWN.  CLIENT ALSO REPORTED FEELING ILL THE DAY AFTER INJECTION. THIS IS THE 4TH CLIENT TO REPORT ILLNESS, BRUISING, AND PAIN AFTER RECEIVING THIS SHOT.
Nausea, headache, fatigue. Neck and lower back pain. Slight erythema around immunization site.